Technology
September 28, 2011 — Cardiac monitoring company Cardiac Network Inc., along with its joint venture partner Pacific Coast Innovations (PCI) LLC announced it is completing the work on its new Central Monitoring System (CMS). The new system, as described below, was built by the companies relating to the design of a new, technologically advanced monitoring device, related data storage and monitoring infrastructure.
September 28, 2011
News
September 28, 2011 — The 24th annual International Symposium on Endovascular Therapy (ISET) will take place Jan. 15-19, 2012, at the Fontainebleau Miami Beach. More than 1,500 members of the global endovascular community will be in attendance; this includes physicians, researchers, scientists, biomedical engineers, nurses, technologists and other industry professionals. The fields of interventional radiology, interventional cardiology and vascular surgery will be represented, among others.
September 28, 2011
News
September 28, 2011 — A clinical trial by Resverlogix Corp. is evaluating the early effects of a new drug compound in atherosclerotic plaque regression. The study is focused on patients with coronary artery disease who have a low level of high-density lipoprotein cholesterol (HDL-C).
September 28, 2011Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
September 28, 2011 –Ziehm Imaging said its holding company Aton GmbH acquired 100 percent of the United States-based mini C-arm specialist OrthoScan Inc.
September 28, 2011
Case Study | Parag V. Patel, DO, FACC, Advocate Lutheran General Hospital, Park Ridge, Ill.
T-wave alternans (TWA) refers to an alternating pattern in the T-wave of the electrocardiogram (ECG) and is recognized as a marker of electrical instability. Visible or macroscopic alternans was first reported in the context of proarrhythmic conditions including Prinzmetal’s angina and long QT syndrome, and was often found to immediately precede the onset of ventricular tachycardia or fibrillation. More recently, techniques have been developed to measure microvolt-level T-wave alternans (MTWA) not visible to the human eye. The presence of MTWA has been linked with increased risk of sudden cardiac arrest (SCA) in several patient populations. This study presents the case of a patient who experienced VF during the recovery phase of an MTWA stress test. While there was no visible abnormality on the ECG which would alert to the impending arrhythmia, significant microvolt-level alternans was detected immediately prior to the cardiac arrest.
September 27, 2011
Technology
September 27, 2011 – Calgary Scientific Inc. has received clearance from the U.S. Food and Drug Administration (FDA) to market medical imaging application, ResolutionMD Mobile, as a mobile diagnostic application in the United States. With this secure, highly scalable, server-based software solution, physicians anywhere can rapidly access, view and interact with patient images and reports stored within any healthcare facility, and render a clinical diagnosis using their mobile devices. Prior non-diagnostic versions of this product are currently distributed and licensed under original equipment manufacturer (OEM) agreements with global leaders in medical imaging and information technology. In addition to the recent FDA clearance, ResolutionMD Mobile has also been licensed by Health Canada and bears the CE mark for distribution in Europe.
September 27, 2011Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024Technology
Toshiba will showcase its proprietary non-contrast magnetic resonance (MR) angiography imaging techniques and a new ...
September 27, 2011
Technology
Toshiba will showcase the Vantage Titan 3.0T MR system at the 2011 Radiological Society of North America (RSNA) trade show. The machine is equipped with multi-phase transmission technology, creating the most homogeneous abdominal and pelvic images on 3.0T systems.
September 27, 2011
News
September 27, 2011 — AccessClosure Inc. announced the shipment of its one millionth Mynx unit. The Mynx Vascular Closure Device received U.S. Food and Drug Administration (FDA) approval in May 2007, following with its full commercial launch in September 2007.
September 27, 2011Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
September 27, 2011 – Health 2.0 announced the launch of the Novartis CardioEngagement Challenge, asking multi-disciplinary teams of developers to create an interactive solution enabling patients to better manage their cardiovascular health through a customizable, user-friendly interface.
September 27, 2011News
September 27, 2011 — Occlutech announced its CEO, Tor Peters, has obtained a favorable ruling from the district court in Düsseldorf in patent litigation initiated personally against him by St. Jude AGA Medical. Occlutech is a European developer of implants for treating structural heart disease.
September 27, 2011
Technology
September 27, 2011 — AF Stat released updates to the AFib Educator, a free smartphone app and desktop widget designed to help healthcare providers better explain atrial fibrillation (AFib) to their patients.
September 27, 2011Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
September 27, 2011 — A team of physicians, engineers and materials scientists at Children's Hospital Boston and the Massachusetts Institute of Technology (MIT) have created cardiac patches, with cells all beating in time, that could someday help heart attack patients. The devices were created using nanotechnology and tiny gold wires.
September 27, 2011News
September 27, 2011 — Last week’s inclusion of critical congenital heart disease (CCHD) in the standard list of recommended screenings for new babies by the Department of Health and Human Services (HHS) has received support from the American College of Cardiology (ACC).
September 27, 2011
News
September 27, 2011 — A study in the Sept. 27 issue of the Journal of the American College of Cardiology suggests that early coronary computed tomographic angiography (CCTA) is preferable to rest-stress myocardial perfusion imaging (MPI) when evaluating acute low-risk chest pain in the emergency department.
September 27, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now